Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H24N2 |
Molecular Weight | 280.4073 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC(CC1)N(CC2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=VZSXTYKGYWISGQ-UHFFFAOYSA-N
InChI=1S/C19H24N2/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17/h2-11,19H,12-16H2,1H3
Molecular Formula | C19H24N2 |
Molecular Weight | 280.4073 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Bamipine (trade name Soventol) is a sedating antihistamine with pronounced sedative effects. Bamipine is a pharmaceutical drug acting as an H1 antihistamine with anticholinergic properties. It is used as an antipruritic ointment. Bamipine hydrochloride has been given by mouth. Bamipine, bamipine lactate, and bamipine salicylate have all been applied topically.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.mims.com/india/drug/info/bamipine?type=full&mtype=generic http://www.medindia.net/doctors/drug_information/bamipine.htm
Curator's Comment: Can be used topically: A thin layer applied on the surface of the skin. Re-application is possible in 30 min. Duration of treatment depends on allergic process. http://www.druginfosys.com/drug.aspx?drugcode=1567&type=1
The recommended dose is 50-100 mg 3-4 times/day.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18977145
Bamipine treatment resulted in 29% of inhibition of Mycobacterium tuberculosis H37Rv (after 4 days by microplate alamar blue assay) at 6.25 ug/mL.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:50:13 GMT 2023
by
admin
on
Sat Dec 16 17:50:13 GMT 2023
|
Record UNII |
Y6BHZ28O92
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QR06AX01
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
||
|
WHO-ATC |
D04AA15
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
||
|
WHO-VATC |
QD04AA15
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
||
|
WHO-ATC |
R06AX01
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06098MIG
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
72075
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
288
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
DTXSID5057751
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL520400
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
m2219
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
225-587-2
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
100000088409
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
C76058
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
1285
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
DB13489
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
Y6BHZ28O92
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
18753
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | RxNorm | ||
|
BAMIPINE
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
4945-47-5
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY | |||
|
C020867
Created by
admin on Sat Dec 16 17:50:13 GMT 2023 , Edited by admin on Sat Dec 16 17:50:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |